Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Reproductive Health
Closing the gap: how Revvity and Women’s Health Hub Finland are advancing women’s healthcare.
August 25, 2025 -
3 min read
Reproductive Health
Building tomorrow - the professional journey of an SMA scientist.
August 25, 2025 -
2 min read
Reproductive Health
Uniting for early detection: the role of Revvity in DMD screening.
August 16, 2025 -
6 min read
Reproductive Health
Minimizing false positives in newborn screening is a critical priority.
July 18, 2025 -
5 min read
Reproductive Health
Early intervention matters: the value of first-trimester preeclampsia screening.
April 17, 2025 -
5 min read
Reproductive Health
Revolutionizing newborn screening: next-generation sequencing in genetic disease research.
March 7, 2025 -
3 min read
Reproductive Health
Empowering lives: Revvity's commitment to rare disease awareness.
February 19, 2025 -
3 min read
Reproductive Health
World prematurity day: understanding the link between premature birth and preeclampsia.
November 5, 2024 -
3 min read
Reproductive Health
The importance of newborn screening software: enhancing efficiency, accuracy, and patient care.
October 1, 2024 -
7 min read
